Composition
Each capsule contains: Anethol, borneol, fenchone, alpha and beta pinene, D-camphene and cineol, in olive oil.
Properties
The therapeutic effects of ROWATINEX® in urinary tract disorders is due to its appropriate balanced combination of different components.
In renal and urinary tract disorders an obvious rapid improvement is achieved, leading to elimination of the complaints through improving the renal blood flow, thus stimulating the kidneys and giving rise to increased urine excretion; elimination of stasis; prevention of urinary tract infections resulting from stasis; an increase in the protective colloids in the urine which effectively prevents stone formation and inflammations; and relieves the inflammation of urinary tract and disorders with urolithiasis which usually improve within a very short time.
A regular daily administration of ROWATINEX® reduces the frequency of renal colic and the attacks eventually cease.
In many cases the antispasmodic action of the drug facilitates the elimination of calculi.
ROWATINEX® capsule, being soluble in the small intestine, suits patients with sensitive stomachs.
Indications
- Treatment and prophylaxis of urolithiasis and nephrolithiasis
- Urinary tract infections
- Renal colic
Contraindications
None known.
Dosage
1-2 capsules 3 times dialy, half an hour before meals.
How Supplied
- Strips of 15 capsules in packs of 2 strips.
- Storage: Store in a cool dry place, below 25 C.
Keep all medicaments out of reach of children
Product of: AMOUN PHARMACEUTICAL CO. El-Obour City, Cairo, Egypt.